Gapping down:
In reaction to disappointing earnings/guidance: SOHU -5.7%, HAE -2.9% (ticking lower), CYOU -2.4%, EDU -2%, NOV -1.1%.
M&A news: MYL -2.7% (Meda AB Board of Directors decided to reject Mylan's proposal to combine the two businesses ), NEM -5.5% (Newmont terminates merger discussions with ABX), .
A few European financial related names showing modest weakness: NBG -2.5%, AIBYY -2.1%, RBS -1.8% .
Select metals/mining stocks trading lower: RIO -1.9%, VALE -1.6%, GFI -1.2%, BHP -1.1%, BBL -0.7%, SLV -0.5%, GLD -0.2%, GDX -0.2%.
Other news: ATHX -52.4% (announces results from Phase 2 study of multistem cell therapy for ulcerative colitis; multistem demonstrates good tolerability and safety profile but fails to show efficacy over 8 weeks in patients with chronic, advanced ulcerative colitis), OGXI -47.4% (Teva Pharma and OncoGenex announce survival results of Phase III SYNERGY Trial; addition of custirsen to standard first-line docetaxel/prednisone therapy did not meet primary endpoint), POZN -28.8% (PA8140/PA32540 receives a Complete Response letter from FDA citing issues at a facility of a third party supplier of an active ingredient ), NBG -2.5% (still checking), SI -1.8% (Siemens AG submits letter to the Board of Alstom (ALSMY) to signal its willingness to discuss future strategic opportunities; also Siemens AG plans to sell VAI unit to Mitsubishi Heavy (MHVYF), according to reports ), GLOG -0.6% (announces commencement of an IPO of 8.4 mln common units representing limited partnership interests ), ILMN -0.4% (Illumina files new patent infringement suit against Ariosa Diagnostics).
Analyst comments: APD -0.7% (downgraded to Underweight from Neutral at Atlantic Equities), BCE -0.3% (downgraded to Sector Perform at RBC Capital Mkts)
M&A news: MYL -2.7% (Meda AB Board of Directors decided to reject Mylan's proposal to combine the two businesses ), NEM -5.5% (Newmont terminates merger discussions with ABX), .
A few European financial related names showing modest weakness: NBG -2.5%, AIBYY -2.1%, RBS -1.8% .
Select metals/mining stocks trading lower: RIO -1.9%, VALE -1.6%, GFI -1.2%, BHP -1.1%, BBL -0.7%, SLV -0.5%, GLD -0.2%, GDX -0.2%.
Other news: ATHX -52.4% (announces results from Phase 2 study of multistem cell therapy for ulcerative colitis; multistem demonstrates good tolerability and safety profile but fails to show efficacy over 8 weeks in patients with chronic, advanced ulcerative colitis), OGXI -47.4% (Teva Pharma and OncoGenex announce survival results of Phase III SYNERGY Trial; addition of custirsen to standard first-line docetaxel/prednisone therapy did not meet primary endpoint), POZN -28.8% (PA8140/PA32540 receives a Complete Response letter from FDA citing issues at a facility of a third party supplier of an active ingredient ), NBG -2.5% (still checking), SI -1.8% (Siemens AG submits letter to the Board of Alstom (ALSMY) to signal its willingness to discuss future strategic opportunities; also Siemens AG plans to sell VAI unit to Mitsubishi Heavy (MHVYF), according to reports ), GLOG -0.6% (announces commencement of an IPO of 8.4 mln common units representing limited partnership interests ), ILMN -0.4% (Illumina files new patent infringement suit against Ariosa Diagnostics).
Analyst comments: APD -0.7% (downgraded to Underweight from Neutral at Atlantic Equities), BCE -0.3% (downgraded to Sector Perform at RBC Capital Mkts)